Increased insulin-like growth factor-1 after oophorectomy in postmenopausal women

Fertility and Sterility

Volumn 90, Issue 4, 2008, Pages 1236-1239

  Fogle, Robin H ^a   Chang, Lilly ^a   Patel, Sherfaraz K ^a   Stanczyk, Frank Z ^a   Paulson, Richard J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CANCER RISK; COLON CANCER; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

FEMALE; GONADAL STEROID HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; OVARIECTOMY; POSTMENOPAUSE; POSTOPERATIVE PERIOD;

EID: 52949116488     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.08.028     Document Type: Article

References (45)

1. Moschos S.J., and Mantzoros C.S. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63 (2002) 317-332
2. Ma J., Pollak M.N., Giovannucci E., Chan J.M., Tao Y., Hennekens C.H., et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-1 and IGF-binding protein-3. J Natl Cancer Inst 91 (1999) 620-625
3. Renehan A.G., Jones J., Potten C.S., Shalet S.M., and O'Dwyer S.T. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. Br J Cancer 83 (2000) 1344-1350
4. Renehan A.G., Zwahlen M., Minder C., O'Dwyer S.T., Shalet S.M., and Egger M. Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 (2004) 1346-1353
5. Probst-Hensch N.M., Yuan J.-M., Stanczyk F.Z., Gao Y.-T., Ross R.K., and Yu M.C. IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai. Br J Cancer 85 (2001) 1695-1699
6. Palmqvist R., Hallmans G., Rinaldi S., Biessy C., Stenling R., Riboli E., et al. Plasma insulin-like growth factor I, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden. Gut 50 (2002) 642-646
7. Mantzoros C.S., Tzonou A., Signorello L.B., Stampfer M., Trichopoulos D., and Adami H.O. Insuling-like growth factor I in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 76 (1997) 1115-1118
8. Chan J.M., Stampfer M.J., Giovannucci E., Gann P.H., Ma J., Wilkinson P., et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 (1998) 563-566
9. Wolk A., Mantzoros C.S., Andersson S.O., Bergstrom R., Signorello L.B., Lagiou P., et al. Insulin-like growth factor I and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 90 (1998) 911-915
10. Shaneyfelt T., Husein R., Bubley G., and Mantzoros C.S. Hormonal predictors of prostate cancer: a meta-analysis. J Clin Oncol 18 (2000) 847-853
11. Khosravi J., Diamandi A., Mistry J., and Scorilas A. Insulin-like growth factor I (IGF-1) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer. J Clin Endocrinol Metab 86 (2001) 694-699
12. Hankinson S.E., Willett W.C., Colditz G.A., Hunter D.J., Michaud D.S., Deroo B., et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 (1998) 1393-1396
13. Toniolo P., Bruning P.F., Akhmedkhanov A., Bonfrer J.M., Koenig K.L., Lukanova A., et al. Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88 (2000) 828-832
14. Bohlke K., Cramer D.W., Trichopoulos D., and Mantzoros C.S. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9 (1998) 570-573
15. Leung K.-C., Johannsson G., Leong G.M., and Ho K.K.Y. Estorgen regulation of growth hormone action. Endocr Rev 25 (2004) 693-721
16. Grumbach M.M., and Styne D.M. Puberty: ontogeny, neuroendocrinology, physiology, and disorders. In: Wilson J.D., and Foster D.W. (Eds). Williams textbook of endocrinology. 8th ed. (1998), W.B. Saunders Company, Philadelphia 1139-1221
17. Helle S.I., Anker G.B., Meadows K.A., Holly J.M., and Lonning P.E. Alterations in the insulin-like growth factor system during the menstrual cycle in normal women. Maturitas 28 (1998) 259-265
18. Massa G., Igout A., Rombauts L., Frankenne F., and Vanderschueren-Lodeweyckx M. Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women. Clin Endocrinol 39 (1993) 569-575
19. Cano A., Castelo-Branco C., and Tarin J.J. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels. Fertil Steril 71 (1999) 261-267
20. Vestergaard P., Hermann A.P., Orskov H., and Mosekilde L. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study. J Clin Endocrinol Metab 84 (1999) 2286-2290
21. Goodman-Gruen D., and Barrett-Connor E. Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: the Rancho Bernardo Study. J Clin Endocrinol Metab 81 (1996) 4268-4271
22. Weissberger A.J., Ho K.K., and Lazarus L. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72 (1993) 302-308
23. Grodstein F., Newcomb P.A., and Stampfer M.J. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 106 (1999) 574-582
24. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288 (2002) 321-333
25. Fogle R.H., Stanczyk F.Z., Zhang X., Roy S., and Paulson R.J. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab 92 (2007) 3040-3043
26. Judd H.L., Lucas W.E., and Yen S.S.C. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol 118 (1974) 793-798
27. Judd H.L., Judd G.E., Lucas W.E., and Yen S.S.C. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 39 (1974) 1020-1024
28. Aiman J., Forney J.P., and Parker C.R. Secretion of androgens and estrogens by normal and neoplastic ovaries in postmenopausal women. Obstet Gynecol 68 (1986) 1-5
29. Lucisano A., Acampora M.G., Russo N., Maniccia E., Montemurro A., and Dell'Acqu S. Ovarian and peripheral plasma levels of progestogens, androgens and oestrogens in post-menopausal women. Maturitas 6 (1984) 45-53
30. Sluijmer A.V., Heineman M.S., De Jong F.H., and Evers J.L.H. Endocrine activity of the postmenopausal ovary: the effects of pituitary down-regulation and oophorectomy. J Clin Endocrinol Metab 80 (1995) 2163-2167
31. Laughlin G.A., Barrett-Connor E., Kritz-Silverstein D., and von Muhlen D. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 85 (2000) 645-651
32. Nagamani M., Hannigan E.V., Dillard E.A., and Dinh T.V. Ovarian steroid secretion in postmenopausal women with and without endometrial cancer. J Clin Endocrinol Metab 62 (1986) 508-512
33. Greenblatt R.B., Colle M.L., and Mahesh V.B. Ovarian and adrenal steroid production in the postmenopausal woman. Obstet Gynecol 47 (1976) 383-387
34. Goebelsmann U., Bernstein G.S., Gale J.A., et al. Serum gonadotropin testosterone estradiol and estrone levels prior to and following bilateral vasectomy. In: Lepow I.H., and Crozier R. (Eds). Vasectomy: immunologic and pathophysiologic effects in animals and man (1979), Academic Press, New York 165
35. Goebelsmann U., Horton R., Mestman J.H., Arce J.J., Nagata Y., Nakamura R.M., et al. Male pseudohermaphroditism due to testicular 17-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 36 (1973) 867
36. Braban G., von zur Mühlen A., Wüster C., Ranke M.B., Kratzsch J., Kiess W., et al. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res 60 (2003) 53-60
37. Michell N.P., Langman M.J., and Eggo M.C. Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers. Br J Cancer 76 (1997) 60-66
38. Guo Y.S., Narayan S., Yallampalli C., and Singh P. Characterization of insulin-like growth factor I receptors in huma colon cancer. Gastroenterology 102 (1992) 1101-1108
39. Remacle-Bonnet M.M., Garrouste F.L., Heller S., Andre F., Marvaldi J.L., and Pommier G.J. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways. Cancer Res 60 (2000) 2007-2017
40. Akagi Y., Liu W., Zebrowski B., Xie K., and Ellis L.M. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. Cancer Res 58 (1998) 4008-4014
41. Murphy L.J., and Friesen H.G. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I expression in the ovariectomized hypophysectomized rat. Endocrinology 122 (1988) 325-332
42. Voutilainen R., Franks S., Mason H.D., and Nartikainen H. Expression of insulin-like growth factor (IGF), IGF-binding protein, and IGF receptor messenger ribonucleic acids in normal and polycystic ovaries. J Clin Endocrinol Metab 81 (1996) 1003-1008
43. Penarrubia J., Balasch J., Garciá-Bermúdez M., Casamitjana R., Vanrell J.A., and Hernandez E.R. Growth hormone does not increase the expression of insulin-like growth factors and their receptor genes in the pre-menopausal human ovary. Hum Reprod 15 (2000) 1241-1246
44. Hernandez E.R., Hurwitz A., Vera A., Pelicer A., Adashi E.Y., LeRoith D., et al. Expression of the genes encoding the insulin-like growth factors and their receptors in the human ovary. J Clin Endocrinol Metab 74 (1992) 419-425
45. Jorgensen J.O.L., Christensen J.J., Vestergaard E., Fisker S., Ovesen P., and Christiansen J.S. Sex steroids and the growth hormone/insulin-like growth factor-I axis in adults. Horm Res 64 (2005) 37-40